![David Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
David Gordon served as the Chief Medical Officer at Aclaris Therapeutics, Inc. from 2018 to 2022.
Prior to that, he was the SVP and Head of Dermatology Research & Development at GSK Plc from 2016 to 2018.
Dr. Gordon earned a doctorate degree from the University of Aberdeen.
Precedenti posizioni note di David Gordon
| Società | Posizione | Fine |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 07/01/2022 |
| GSK PLC | Direttore Tecnico/Scientifico/R&S | 01/03/2018 |
Formazione di David Gordon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
84
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
